Taken together, these results suggested that in OCT4wt overexpressing HCC, sorafenib-induced SCF expression and simultaneous activation of c-KIT and FLT3 signaling is indispensable for OCT4wt mediated sorafenib resistance. Here, KITLG is linked to hepatocellular carcinoma.